Influence on Human Male Fertility of Testosterone After Intranasal (MPP10) or Transdermal (AndroGel) Application

Trial Profile

Influence on Human Male Fertility of Testosterone After Intranasal (MPP10) or Transdermal (AndroGel) Application

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 03 May 2012

At a glance

  • Drugs Testosterone; Testosterone
  • Indications Hypogonadism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 May 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 19 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top